INTRODUCTION
============

Described by Jablonska *et al* in 1975, pemphigus herpetiformis (PH) is a rare pemphigus variant that associates the clinical features of dermatitis herpetiformis (DH) and linear IgA bullous dermatosis (LABD) with a heterogenous histology and direct immunofluorescence (DIF) similar to pemphigus - intercellular intraepidermal pattern.^[@r1]^

PH has autoantibodies directed against desmoglein-1, less frequently against desmoglein-3 and rarely against desmocollins; sometimes no antigen is identified.^[@r1]-[@r4]^

Its incidence is of 6-7% among pemphigus patients, with no gender predilection, affecting the age group from 5 to 92 years.^[@r5],[@r6]^ It manifests clinically as urticarial, annular plaques, with vesicles/ bullae in the periphery, located on the trunk and proximal limbs, associated to intense pruritus, with no mucosal involvement. ^[@r1],[@r5]^

CASE REPORT
===========

Forty-one-year-old female patient, phototype IV, with recurrent, itchy, erythematous-edematous annular plaques, with overlying vesicles and crusts on the trunk and limbs for 3 years ([Figures 1](#f1){ref-type="fig"} and [2](#f2){ref-type="fig"}). The diagnostic considerations were of dermatitis herpetiformis and linear IgA bullous dermatosis. She was treated with antihistamines, emollients and gluten-free diet. Hepatitis, HIV and syphilis serologies were negative; blood count, liver and renal function tests were normal. Anti-endomysial, anti-transglutaminase and anti-gliadin antibodies were negative. Histopathology revealed mild acantholysis simulating spongiosis, exocytosis and perivascular inflammatory infiltrate in one of the biopsies, and acantholytic vesicle containing neutrophils and eosinophils in the other ([Figures 3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). DIF demonstrated intercellular IgG and C3 in the epidermis, in a pemphigus pattern, ruling out the previous suspicions of DH, that would present with a deposit at the top of dermal papillae and LABD, that would present with a linear deposit of IgA along the basement membrane zone ([Figure 5](#f5){ref-type="fig"}).

Figure 1Erythematous, edematous annular plaques with centrifugal growth

Figure 2Erythematous, edematous plaques with overlying vesicles in a herpetiform pattern

Figure 3Exocytosis and mild acantholysis simulating spongiosis, besides predominantly mononuclear perivascular inflammatory infiltrate (Hematoxylin & eosin, X100)

Figure 4Intraepidermal acantholytic blister with numerous eosinophils, also seen in the adjacent epidermis (Hematoxylin & eosin, X100)

Figure 5Deposition of IgG in an intercellular pattern all over the epidermis (IFD, X100)

In face of the clinical features of herpetiform lesions and DIF in a pemphigus pattern, the conclusion was pemphigus herpetiformis. Treatment was commenced with dapsone, with partial improvement. However, at the dose of 100 mg/day, the patient developed hemolytic anemia and the medication was replaced with prednisone 40 mg/day, that provided complete clinical remission within a few days. To taper prednisone, we added mycophenolate mofetil 1000mg/day.

DISCUSSION
==========

The patient had annular and circinate urticarial lesions, with small grouped vesicles and pustules, frequently in a herpetiform pattern or in the periphery of the plaques, like a "string of pearls" (term frequently used for LABD), intensely pruritic. They were localized on the trunk and proximal extremities, as described by Jablonska *et al.* ^[@r1]^

Histopathology is heterogenous, according to the clinical stage of the lesions, ranging from spongiosis with exocytosis to the typical or minimal acantholysis, more than one biopsy being sometimes needed in different phases in order to visualize the acantholysis, as with the reported patient. The inflammatory infiltrate in the biopsies of PH patients is predominantly composed of eosinophils (68%), neutrophils (16%) and mixed (16%), according to Huhn *et al.* Peripheral eosinophilia can occur in some patients.^[@r5],[@r7]^ In our case, four biopsies were performed in different departments. The first two showed spongiotic dermatitis with the formation of blisters, and the presence of neutrophils and eosinophils. In the third, there was mild exocytosis and acantholysis, simulating spongiosis. In the fourth, an intraepidermal acantholytic blister was seen, containing multiple eosinophils, as already described.^[@r7]^

Perilesional skin DIF shows the presence of intercellular IgG and C~3~ in the epidermis, as in the reported case, characterizing it as a variant of pemphigus, crucial for the diagnosis. ^[@r5]^

PH has a relatively benign course and good response to treatment with dapsone, the drug of choice, or low-dose systemic corticosteroids, such as in our patient.^[@r6]^ The use of immunosuppressants such as azathioprine and cyclophosphamide must be considered according to the severity of each case and as a way of avoiding the side effects of systemic corticosteroids.^[@r2],[@r5],[@r8]^ Mycophenolate mofetil 500 mg twice daily was added with the intent to gradually taper the corticosteroid.

Some rare reports have demonstrated an association with lung, esophagus and prostate cancers, cutaneous angiosarcoma, infections (HIV), inflammatory conditions (systemic lupus erythematosus, psoriasis) and drugs. However, due to the rarity of this condition, it would be precocious to assume a paraneoplastic character of PH, more studies being needed regarding this association.^[@r5],[@r9]^

Recognizing PH is extremely important for the dermatologist, because the therapeutic approach differs from the other types of pemphigus, determining another course for the disease with improvement in the patient's quality of life.

Besides, it is important to highlight that since it can clinically mimic other bullous diseases (DH and LABD) and that the histopathology can be inconclusive (depending on the stage of the disease), the finding of epidermal intercellular IgG and C3 on DIF is extremely important for establishing a diagnosis.
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